The Company was founded by Michael G. Curley, Ph.D., FHRS, and Patrick S. Hamilton, Ph.D. who met at the M.I.T. Hyperthermia Center as graduate students.
The Company was reorganized in Delaware as Thermedical in 2008. In 2012, the Thermedical® Ablation System and the Ablation Needle received initial U.S. Food & Drug Administration (FDA) clearance for the coagulation and ablation of soft tissue during percutaneous, laparoscopic, and intraoperative surgical procedures. This clearance was based on substantial preclinical testing carried out under multiple Small Business Innovation Research (SBIR) Grants from the National Institutes of Health (NIH) and on a matching grant from the Massachusetts Life Sciences Center.